CN104857116A - Applications of traditional Chinese medicine sanguisorba officinalis in preparing antifungal drug synergist - Google Patents
Applications of traditional Chinese medicine sanguisorba officinalis in preparing antifungal drug synergist Download PDFInfo
- Publication number
- CN104857116A CN104857116A CN201410060182.1A CN201410060182A CN104857116A CN 104857116 A CN104857116 A CN 104857116A CN 201410060182 A CN201410060182 A CN 201410060182A CN 104857116 A CN104857116 A CN 104857116A
- Authority
- CN
- China
- Prior art keywords
- burnet
- drug
- antifungal drugs
- antifungal
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
本发明涉及医药技术领域,具体涉及中药地榆在制备抗真菌药物增效剂中的应用。本发明经体外实验证实,地榆对氟康唑,咪康唑,卡泊芬净,两性霉素B等常规抗真菌药物有增效作用,对于耐药真菌,抗真菌药物与地榆合用时,能明显降低常规抗真菌药物的药物剂量,能不同程度地提高常用抗真菌药对真菌的抑制作用,并能使抗真菌药物恢复对耐药真菌的作用,增强对耐药真菌的抑制作用。本发明为中药地榆开辟了新的用途,在临床真菌耐药性日趋普遍、耐药程度日趋严重的情况下,可降低抗真菌药物的用药剂量,为患者节省了医疗费用,并可减少药物的毒副作用。The invention relates to the technical field of medicine, in particular to the application of traditional Chinese medicine Burnet eucalyptus in the preparation of synergists for antifungal drugs. The present invention has been confirmed by in vitro experiments that Burnet has synergistic effects on conventional antifungal drugs such as fluconazole, miconazole, caspofungin, and amphotericin B. For drug-resistant fungi, when antifungal drugs are used in combination with Burnet , can significantly reduce the drug dosage of conventional antifungal drugs, can improve the inhibitory effect of commonly used antifungal drugs on fungi to varying degrees, and can restore the effect of antifungal drugs on drug-resistant fungi, and enhance the inhibitory effect on drug-resistant fungi. The invention opens up a new application for the traditional Chinese medicine Sanguis Burnet, and can reduce the dosage of antifungal drugs under the condition that the drug resistance of clinical fungi is becoming more and more common and the degree of drug resistance is becoming more and more serious, which saves medical expenses for patients and reduces the cost of drugs. toxic side effects.
Description
技术领域 technical field
本发明涉及医药技术领域,具体涉及中药地榆在制备抗真菌药物增效剂中的应用。 The invention relates to the technical field of medicine, in particular to the application of traditional Chinese medicine Burnet eucalyptus in the preparation of synergists for antifungal drugs. the
背景技术 Background technique
地榆为蔷薇科植物地榆(Sanguisorba officinalis L)或长叶地榆(Sanguisorba officinalis L.var.longifolia(Bert.)Yüet Li)的干燥根。我国全国各地均有产,主产于浙江、安徽、山东、湖南、湖北等地。地榆性微寒,味苦、涩、酸,归肝、胃、大肠经,有凉血止血、解毒敛疮等功效,临床常用于便血、痔血、血痢、崩漏、水火烫伤、通肿疮毒等病症的治疗(参见:清·孙星衍,孙星翼辑.神农本草经[M].北京:商务印书馆,1955.94.)。 Burnet is the dry root of Sanguisorba officinalis L or Sanguisorba officinalis L.var.longifolia (Bert.) Yüet Li, a plant of the family Rosaceae. It is produced all over the country, mainly in Zhejiang, Anhui, Shandong, Hunan, Hubei and other places. Burnet eucalyptus is slightly cold in nature, bitter, astringent, and sour. It returns to the liver, stomach, and large intestine meridian. Treatment of diseases such as swollen sores (see: Qing Sun Xingyan, Sun Xingyi Series. Shennong's Herbal Classic [M]. Beijing: Commercial Press, 1955.94.). the
地榆也具备有抗菌消炎的作用,但主要集中于金黄色葡萄球菌,铜绿假单胞菌等细菌(参见文献:吴开云,黄雪芳,彭宣宪.冰片、虎杖、地榆抑菌作用的实验研究[J].江西医学院学报,l996,36(2):53-55.)。地榆主要为生用或炒炭用。生地榆是未经炮制的地榆饮片,常研磨外用治疗水火烫伤、湿疹、皮肤溃疡等疾病,有收敛吸湿的作用。地榆炭是用炒炭法炮制的地榆饮片,止血作用强,疗效胜于生地榆。将生地榆粗提物分别用石油醚、乙酸乙酯、正丁醇、水萃取后检测其抗真菌的活性,发现乙酸乙酯萃取部分的抗菌活性效果最好。 Burnet also has antibacterial and anti-inflammatory effects, but it is mainly concentrated on Staphylococcus aureus, Pseudomonas aeruginosa and other bacteria (see literature: Wu Kaiyun, Huang Xuefang, Peng Xuanxian. Experimental research on the antibacterial effects of borneol, Polygonum cuspidatum, and Burnet [J ]. Jiangxi Medical College Journal, l996,36(2):53-55.). Burnet is mainly used raw or fried charcoal. Raw Burnet is unprocessed Burnet decoction pieces. It is often ground and used externally to treat water and fire burns, eczema, skin ulcers and other diseases. It has the effect of astringent and moisture absorption. Burnet charcoal is a decoction piece of Burnet that is prepared by frying charcoal. It has a strong hemostatic effect, and its curative effect is better than that of raw Burnet. The raw Burnet crude extract was extracted with petroleum ether, ethyl acetate, n-butanol, and water to detect its antifungal activity, and it was found that the antibacterial activity of the ethyl acetate extract was the best. the
目前尚未见地榆有关抗真菌的报道,也未见其作为协同抗真菌增效药物的相关报道。 At present, there is no report about the antifungal effects of Burnet, nor is there any report about it as a synergistic antifungal synergistic drug. the
发明内容 Contents of the invention
本发明的目的在于提供中药地榆的新的医药用途。 The purpose of the present invention is to provide a new medical application of traditional Chinese medicine Sangui. the
本发明提供了中药地榆作为抗真菌药物增效药的新用途,即地榆在制备抗真菌药物增效剂中的应用。 The invention provides a new application of the traditional Chinese medicine Burnet eucalyptus as an antifungal drug synergist, that is, the application of Burnet eucalyptus in the preparation of an antifungal drug synergist. the
本发明所述的中药地榆(地榆),包括地榆的两种不同炮制药材——生地榆和地榆炭。也包括通过乙酸乙酯萃取等方法提取到的地榆的活性成份。 The traditional Chinese medicine Burnet (burnet) of the present invention includes two different medicinal materials of Burnet—raw Burnet and Burnet charcoal. It also includes the active ingredient of Burnet extracted by ethyl acetate extraction and other methods. the
本发明所述的抗真菌药物为常规抗真菌药物,包括但不限于氟康唑、卡泊芬净、特比萘芬、两性霉素B等。 The antifungal drugs described in the present invention are conventional antifungal drugs, including but not limited to fluconazole, caspofungin, terbinafine, amphotericin B and the like. the
本发明经体外实验证实,地榆对氟康唑,咪康唑,卡泊芬净,两性霉素B等常规抗真菌药物有增效作用,对于耐药真菌,抗真菌药物与地榆合用时,能明显降低常规抗真菌药物的药物剂量,能不同程度地提高常用抗真菌药对真菌的抑制作用,并能使抗真菌药物恢复对耐药真菌的作用,增强对耐药真菌的抑制作用。 The present invention has been confirmed by in vitro experiments that Burnet has synergistic effects on conventional antifungal drugs such as fluconazole, miconazole, caspofungin, and amphotericin B. For drug-resistant fungi, when antifungal drugs are used in combination with Burnet , can significantly reduce the drug dosage of conventional antifungal drugs, can improve the inhibitory effect of commonly used antifungal drugs on fungi to varying degrees, and can restore the effect of antifungal drugs on drug-resistant fungi, and enhance the inhibitory effect on drug-resistant fungi. the
本发明为中药地榆开辟了新的用途,将其用于抗真菌药物的增效剂,不仅能提高药物的抗真菌作用,而且在临床真菌耐药性日趋普遍、耐药程度日趋严重的情况下,使抗真菌药物恢复对耐药真菌的作用,可降低抗真菌药物的用药剂量,为患者节省了医疗费用,并可减少药物的毒副作用。 The invention opens up a new application for the traditional Chinese medicine Burnet elata, and using it as a synergist of antifungal drugs can not only improve the antifungal effect of the drug, but also become more common and more serious in clinical fungal drug resistance. Under the circumstances, the antifungal drugs can restore the effect on drug-resistant fungi, which can reduce the dosage of antifungal drugs, save medical expenses for patients, and reduce the toxic and side effects of drugs. the
本发明的中药地榆是我国传统药物,具有资源丰富,价格便宜,副作用小等优点,地榆和抗真菌药物合用也能够减少药物的毒副作用,节省患者的医药费用。 The traditional Chinese medicine Burnet eucalyptus of the present invention is a traditional medicine in my country and has the advantages of abundant resources, low price and less side effects, and the combined use of Burnet eucalyptus and antifungal drugs can also reduce the toxic and side effects of drugs and save the medical expenses of patients. the
具体实施方式 Detailed ways
现结合实施例,对本发明作详细描述,但本发明的实施不仅限于此。 Now, the present invention will be described in detail in conjunction with the embodiments, but the implementation of the present invention is not limited thereto. the
实施例1:生地榆与抗真菌药联用7株念珠菌的作用 Embodiment 1: The effect of raw Burnet and antifungal drugs combined with 7 strains of Candida
一、材料和方法 1. Materials and methods
1、试剂 1. Reagents
生地榆:上海雷允上医药有限公司中药部 Raw Burnet: Department of Traditional Chinese Medicine, Shanghai Leiyunshang Pharmaceutical Co., Ltd.
地榆炭:上海雷允上医药有限公司中药部 Burnet Charcoal: Department of Traditional Chinese Medicine, Shanghai Leiyunshang Pharmaceutical Co., Ltd.
氟康唑注射液:辉瑞制药有限公司 Fluconazole injection: Pfizer Pharmaceutical Co., Ltd.
无水乙醇:上海国药集团有限公司 Anhydrous ethanol: Shanghai Sinopharm Group Co., Ltd.
石油醚:上海国药集团有限公司 Petroleum ether: Shanghai Sinopharm Group Co., Ltd.
乙酸乙酯:上海国药集团有限公司 Ethyl acetate: Shanghai Sinopharm Group Co., Ltd.
正丁醇:上海国药集团有限公司 Butanol: Shanghai Sinopharm Group Co., Ltd.
中药提取液的制备:分别取生地榆,地榆炭中药粉末各5g,加入70%的乙醇溶液50ml,于室温下50KHz超声40分钟,冷却后重复超声两次,3000×g,离心5min,取上清液,该药生药浓度为0.1g/mL,放于4℃冰箱保存备用。 Preparation of traditional Chinese medicine extract: Take 5g of raw Burnet and Burnet charcoal Chinese medicine powder respectively, add 50ml of 70% ethanol solution, ultrasonicate at 50KHz for 40 minutes at room temperature, repeat ultrasonication twice after cooling, centrifuge at 3000×g for 5min, and take The supernatant, the crude drug concentration of which is 0.1g/mL, is stored in a 4°C refrigerator for later use. the
生地榆乙酸乙酯萃取液的制备:将保存的中药粗体物40ml,烘干,加水 混悬,分别依次加入萃取液(石油醚、乙酸乙酯、正丁醇)1~1.5倍体积,立即充分震荡混匀,然后静置分液漏斗,待液体分层后,从下端出口接取萃取液,每种萃取液重复多次萃取至萃取液无色或颜色变淡。合并萃取液,旋转蒸干,取少量用DMSO配置成5.12mg/mL的溶液。 Preparation of the ethyl acetate extract of Raw Burnet: Dry 40ml of the preserved traditional Chinese medicinal material, add water to suspend, add 1 to 1.5 times the volume of the extract (petroleum ether, ethyl acetate, n-butanol) respectively, and immediately Shake and mix well, then put the separatory funnel aside, and after the liquid is layered, take the extract from the outlet at the lower end, and repeat the extraction for each extract until the extract is colorless or the color becomes lighter. The extracts were combined, evaporated to dryness, and a small amount was prepared into a 5.12 mg/mL solution with DMSO. the
2、菌株 2. Strains
菌株:白色念珠菌103(简称103)、白色念珠菌SC5314(简称sc5314)、白色念珠菌100(简称100)、克柔念珠菌ATCC2159(简称克柔ATCC2159)、热带念珠菌ATCC087(简称热带ATCC087)、光滑念珠菌ATCC28226(简称光滑ATCC28226)、近平滑念珠菌22090(简称近平22090),均由上海长海医院真菌室提供,分别采自长海医院不同科室临床样本,并经形态学和生化学鉴定,也可购自中科院细胞所或ATCC保藏机构等。 Strains: Candida albicans 103 (abbreviated as 103), Candida albicans SC5314 (abbreviated as sc5314), Candida albicans 100 (abbreviated as 100), Candida krusei ATCC2159 (abbreviated as Kerou ATCC2159), Candida tropicalis ATCC087 (abbreviated as tropical ATCC087) , Candida glabrata ATCC28226 (abbreviated as Smooth ATCC28226), and Candida parapsilosis 22090 (abbreviated as Jinping 22090), all provided by the Fungi Department of Shanghai Changhai Hospital, collected from clinical samples from different departments of Changhai Hospital, and identified by morphology and biochemistry , and can also be purchased from the Institute of Cells, Chinese Academy of Sciences or the ATCC depository, etc. the
所有实验用菌株均于沙堡葡萄糖琼脂培养基(SDA)划板活化,白色念珠菌于30℃培养2周后,分别挑取单克隆再次划板活化,取第二次所得单克隆置SDA斜面,用上述方法培养后于4℃保存备用。 All experimental strains were activated on sandcastle dextrose agar medium (SDA). After Candida albicans was cultured at 30°C for 2 weeks, single clones were picked and activated again, and the single clones obtained for the second time were placed on the SDA slope. , cultured by the above method and stored at 4°C for future use. the
3、培养液 3. Culture medium
沙堡葡萄糖琼脂固体培养基(SDA): Sandcastle dextrose agar solid medium (SDA):
蛋白胨10g,葡萄糖40g,琼脂18g,加三蒸水900ml溶解,加入2mg/ml氯霉素水溶液50ml,调整pH至7.0,以三蒸水定容至1000ml,高压灭菌(121℃15min)后于4℃保存备用。 Add 10g of peptone, 40g of glucose, and 18g of agar, add 900ml of triple-distilled water to dissolve, add 50ml of 2mg/ml chloramphenicol aqueous solution, adjust the pH to 7.0, dilute to 1000ml with triple-distilled water, and sterilize under high pressure (121°C for 15min). Store at 4°C for later use. the
YEPD培养液: YEPD medium:
酵母浸膏10g,蛋白胨20g,葡萄糖20g,加三蒸水900ml溶解,加入2mg/m氯霉素水溶液50ml,三蒸水定容至1000ml,高压灭菌(121℃,15min)后于4℃保存备用。 Yeast extract 10g, peptone 20g, glucose 20g, add 900ml of triple distilled water to dissolve, add 50ml of 2mg/m chloramphenicol aqueous solution, dilute to 1000ml with triple distilled water, autoclave (121°C, 15min) and store at 4°C spare. the
RPMI1640液体培养液: RPMI1640 liquid culture medium:
RPMI1640(Gibco BRL)10g,NaHCO32.0g,吗啡啉丙磺酸(MOPS)(Sigma)34.5g(0.165M),加三蒸水900ml溶解,1N NaOH调pH至7.0(25℃),三蒸水定容至1000ml,0.22μm微孔滤膜过滤除菌,分装后于4℃保存备用。 RPMI1640 (Gibco BRL) 10g, NaHCO 3 2.0g, morpholine propanesulfonic acid (MOPS) (Sigma) 34.5g (0.165M), add three distilled water 900ml to dissolve, 1N NaOH to adjust the pH to 7.0 (25°C), three distilled Dilute the water to 1000ml, filter and sterilize with a 0.22μm microporous membrane, and store it at 4°C after aliquoting.
4、仪器设备 4. Instruments and equipment
MDF1-100手提式高速中药粉碎机(上海市民德机械制造有限公司) MDF1-100 Portable High Speed Traditional Chinese Medicine Grinder (Shanghai Minde Machinery Manufacturing Co., Ltd.)
DF-101S集热式恒温加热磁力搅拌器(巩义市英峪矛华仪器厂) DF-101S collector type constant temperature heating magnetic stirrer (Gongyi Yingyu Maohua Instrument Factory)
SHZ-D(Ⅲ)循环水式真空泵(巩义市英峪矛华仪器厂) SHZ-D(Ⅲ) Circulating Water Vacuum Pump (Gongyi Yingyu Maohua Instrument Factory)
RE-52C旋转蒸发器(上海青浦沪西仪器厂) RE-52C rotary evaporator (Shanghai Qingpu Huxi Instrument Factory)
KQ-C玻璃仪器气流烘干器(巩义市英峪矛华仪器厂) KQ-C Airflow Dryer for Glass Instruments (Gongyi Yingyu Maohua Instrument Factory)
Multiskan MK3型酶标检测仪(芬兰Labsystems产品) Multiskan MK3 enzyme label detector (product of Finnish Labsystems)
全温振荡培养箱(培英,HZQ-F160) Full temperature shaking incubator (Peiying, HZQ-F160)
MJX型智能霉菌培养箱(宁波江南仪器厂) MJX Intelligent Mold Incubator (Ningbo Jiangnan Instrument Factory)
SW-CT-IF型单人双面净化工作台(苏州净化有限公司) SW-CT-IF single-person double-sided purification workbench (Suzhou Purification Co., Ltd.)
生物显微镜(重庆光学仪器厂XSZ-G) Biological Microscope (Chongqing Optical Instrument Factory XSZ-G)
5、菌液制备 5. Preparation of bacterial solution
实验前,从4℃保存的SDA培养基上挑取念珠菌,接种至1ml YEPD培养液,于30℃,200rpm振荡培养,活化两次后,使真菌处于指数生长期后期。取该菌液10ul至1mlYEPD培养液中,用上述方法再次活化,16h后,用血细胞计数板计数,以RPMI1640培养液调整菌液浓度至1×103~5×103个/ml。 Before the experiment, Candida was picked from the SDA medium stored at 4°C, inoculated into 1ml of YEPD medium, and cultured at 30°C with shaking at 200rpm. After two activations, the fungus was in the late exponential growth phase. Take 10ul of the bacteria solution into 1ml YEPD culture solution, and reactivate it by the above method. After 16 hours, count with a hemocytometer, and adjust the concentration of the bacteria solution to 1×10 3 -5×10 3 cells/ml with RPMI1640 culture solution.
6、药敏反应板的制备 6. Preparation of DSR plate
取无菌96孔板,于每排1号孔加RPMI1640液体培养基100μl作空白对照;3~12号孔各加新鲜配制的菌液100μl;2号孔分别加菌液198μl和受试化合物溶液2μl;12号孔不含药物,只加菌液100μl作阳性生长对照。2~11号孔进行倍比稀释,使各孔的最终药物浓度分别为1000、500、250、125、62.5、31.25、15.625、7.8125、3.906和1.953μg/ml,各孔中乙醇含量均低于1%。每次配制药敏板的同时均制备一质控菌药敏板,各药敏板于30℃恒温箱培养。 Take a sterile 96-well plate, and add 100 μl of RPMI1640 liquid medium to No. 1 well of each row as a blank control; add 100 μl of freshly prepared bacterial solution to each of No. 3 to No. 12 wells; add 198 μl of bacterial solution and test compound solution to No. 2 wells respectively 2 μl; No. 12 well does not contain drugs, only 100 μl of bacterial solution is added as a positive growth control. Doubling dilutions were carried out in wells 2 to 11, so that the final drug concentrations in each well were 1000, 500, 250, 125, 62.5, 31.25, 15.625, 7.8125, 3.906 and 1.953 μg/ml, and the ethanol content in each well was lower than 1%. A drug-sensitivity plate of quality control bacteria was prepared each time the drug-sensitivity plate was prepared, and each drug-sensitivity plate was cultured in a 30°C incubator. the
7、最低抑菌浓度(MIC值)的判定 7. Determination of minimum inhibitory concentration (MIC value)
在30℃恒温箱中,白念珠菌培养48h,用酶标分析仪于630nm测各孔OD值。与阳性对照孔比,以OD值下降80%以上的最低浓度孔中的药物浓度为MIC80(真菌生长80%被抑制时的药物浓度)。 Candida albicans was cultured in an incubator at 30°C for 48 hours, and the OD value of each well was measured at 630 nm with an enzyme label analyzer. Compared with the positive control wells, the drug concentration in the lowest concentration well whose OD value drops by more than 80% is MIC 80 (drug concentration when 80% of fungal growth is inhibited).
当药物的MIC80值超过测定浓度范围时,按以下方法进行统计:MIC80值高于最高浓度1000μg/ml时,计为“>1000μg/ml”;氟康唑MIC80值高于最高浓度64μg/ml时,计为“>64μg/ml”;药物MIC80值为最低浓度或在最低浓度以下时,不作区别,均计为“≤1.953μg/ml”;氟康唑MIC80值为最低浓度或在最低浓度以下时,不作区别,均计为“≤0.125μg/ml”。上述实验均平行操作2到3次,当MIC80值能准确重复或只差一个浓度时才被接受,并以较高浓度作为MIC80值;当MIC80值相差两个浓度以上时,则需重新实验,直到符合要求为止。 When the MIC 80 value of the drug exceeds the concentration range of the determination, the following methods are used for statistics: when the MIC 80 value is higher than the highest concentration of 1000 μg/ml, it is counted as “>1000 μg/ml”; the MIC 80 value of fluconazole is higher than the highest concentration of 64 μg /ml, it is counted as ">64μg/ml"; when the drug MIC 80 value is the lowest concentration or below the lowest concentration, it is counted as "≤1.953μg/ml" without distinction; the fluconazole MIC 80 value is the lowest concentration Or when it is below the minimum concentration, no distinction shall be made, and it shall be counted as "≤0.125μg/ml". The above experiments were performed 2 to 3 times in parallel. When the MIC 80 value can be accurately repeated or only differs by one concentration, it is accepted, and a higher concentration is used as the MIC 80 value; when the MIC 80 value differs by more than two concentrations, it is required to Experiment again until you meet the requirements.
二、实验结果见表1。 2. The experimental results are shown in Table 1. the
表1中药生地榆提取液与氟康唑合用对7株念珠菌的抗真菌作用(生药浓度) Table 1 The antifungal effect of the traditional Chinese medicine Burnet eucalyptus extract combined with fluconazole on 7 strains of Candida (crude drug concentration)
由表1中可以看出,生地榆能够对白色念珠菌SC5314,100,103都能够产生协同的效果,地榆和氟康唑合用后能够明显的降低两药的用药浓度,使耐药菌100,103重新对氟康唑变得敏感。对非白色念珠菌克柔ATCC2159,近平22090等菌也有表现出了抗真菌的作用。本实验说明中药地榆具有协同抗真菌的作用。 It can be seen from Table 1 that raw Burnet can produce synergistic effects on Candida albicans SC5314, 100, and 103, and the combination of Burnet and fluconazole can significantly reduce the drug concentration of the two drugs, allowing drug-resistant bacteria 100, 103 to re-affect Sensitive to fluconazole. It also exhibits antifungal effects on non-albicans Candida krusei ATCC2159, Jinping 22090 and other bacteria. This experiment shows that the traditional Chinese medicine Burnet has a synergistic antifungal effect. the
实施例2:生地榆,地榆炭与抗真菌药物合用对白色念珠菌103,SC5314的作用 Embodiment 2: Raw Burnet, the effect of Burnet charcoal and antifungal drugs on Candida albicans 103, SC5314
一、材料和方法 1. Materials and methods
1、药物 1. Drugs
氟康唑注射液辉瑞制药有限公司 Fluconazole Injection Pfizer Pharmaceutical Co., Ltd.
醋酸卡泊芬净Merck sharp&Dohme(I.A.)CORP Singapore Caspofungin Acetate Merck sharp&Dohme (I.A.) CORP Singapore
盐酸特比萘芬西安凯宏生物科技有限公司 Terbinafine Hydrochloride Xi'an Kaihong Biotechnology Co., Ltd.
两性霉素B辉瑞(Pfizer)制药有限责任公司 Amphotericin B Pfizer Pharmaceuticals LLC
二甲基亚砜上海国药集团有限公司 Dimethyl sulfoxide Shanghai Sinopharm Group Co., Ltd.
醋酸卡泊芬净,特比萘芬,两性霉素B用二甲基亚砜溶解配置成6.4mg/ml的溶液,各试药置于-20℃保存。实验前,将药物取出置于35℃温箱融化,充分混匀,分别进行药效学检验。 Caspofungin acetate, terbinafine, and amphotericin B were dissolved in dimethyl sulfoxide to form a 6.4 mg/ml solution, and each reagent was stored at -20°C. Before the experiment, the drug was taken out and placed in a 35°C incubator to melt, mixed well, and pharmacodynamic tests were carried out respectively. the
其他实验步骤和方法同实施例1 Other experimental steps and method are with embodiment 1
二、实验结果见表2,表3,表4,表5。 2. The experimental results are shown in Table 2, Table 3, Table 4, and Table 5. the
表2地榆炭与抗真菌药物合用对耐药白色念珠菌103的作用(生药浓度) Table 2 The effect of Burnet charcoal and antifungal drugs on drug-resistant Candida albicans 103 (crude drug concentration)
表3地榆炭与抗真菌药物合用对白色念珠菌SC5314的作用(生药浓度) Table 3 The effect of Burnet charcoal and antifungal drugs on Candida albicans SC5314 (crude drug concentration)
表4生地榆乙酸乙酯萃取部分药物与抗真菌药物对白色念珠菌103的作用 Table 4 The effect of some drugs extracted from raw Burnet ethyl acetate and antifungal drugs on Candida albicans 103
利用浸膏浓度显示,括号内为生药浓度 The concentration of the extract is displayed, and the concentration of the crude drug is in brackets
表5生地榆乙酸乙酯萃取部分药物与抗真菌药物对白色念珠菌SC5314的作用 Table 5 The effect of some drugs extracted from raw Burnet urnica ethyl acetate and antifungal drugs on Candida albicans SC5314
利用浸膏浓度显示,括号内为生药浓度 The concentration of the extract is displayed, and the concentration of the crude drug is in brackets
由表2,表3,表4,表5中可见,地榆的两种不同的炮制方式生地榆和地榆炭的提取液与氟康唑合用后,发现不管是生地榆还是地榆炭都能够和抗真菌氟康唑合用降低氟康唑的药物浓度,使氟康唑重新对耐药白色念珠菌100,103敏感,并且和卡泊芬净、特比萘芬、两性霉素B等常用的抗真菌药物都能够产生协同的效果,除了卡泊芬净的协同抗真菌的效果比较差,其他药 大部分都能够明显的降低抗真菌药物的用药浓度。 It can be seen from Table 2, Table 3, Table 4, and Table 5 that after combining the extracts of raw Burnet and Burnet charcoal with fluconazole, it was found that both raw Burnet and Burnet charcoal It can be used in combination with antifungal fluconazole to reduce the drug concentration of fluconazole, making fluconazole re-sensitized to drug-resistant Candida albicans100,103, and it is compatible with commonly used antifungal agents such as caspofungin, terbinafine, and amphotericin B. All fungal drugs can produce synergistic effects. Except for caspofungin, which has a relatively poor synergistic antifungal effect, most other drugs can significantly reduce the concentration of antifungal drugs. the
以上实验均证明中药地榆具有协同抗真菌的作用,降低抗真菌药物的给药剂量,因此可用于抗真菌药物的增效剂。 The above experiments all prove that the traditional Chinese medicine Burnet has a synergistic antifungal effect and can reduce the dosage of antifungal drugs, so it can be used as a synergist for antifungal drugs. the
以上已对本发明创造的较佳实施例进行了具体说明,但本发明创造并不限于所述实施例,熟悉本领域的技术人员在不违背本发明创造精神的前提下还可作出种种的等同的变型或替换,这些等同的变型或替换均包含在本申请权利要求所限定的范围内。 The preferred embodiments of the present invention have been specifically described above, but the present invention is not limited to the described embodiments, and those skilled in the art can also make various equivalents without violating the spirit of the present invention. Modifications or replacements, these equivalent modifications or replacements are all included within the scope defined by the claims of the present application. the
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410060182.1A CN104857116B (en) | 2014-02-21 | 2014-02-21 | Application of the Chinese medicine garden burnet in preparing antifungal medicine synergist |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410060182.1A CN104857116B (en) | 2014-02-21 | 2014-02-21 | Application of the Chinese medicine garden burnet in preparing antifungal medicine synergist |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104857116A true CN104857116A (en) | 2015-08-26 |
CN104857116B CN104857116B (en) | 2018-11-02 |
Family
ID=53903583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410060182.1A Expired - Fee Related CN104857116B (en) | 2014-02-21 | 2014-02-21 | Application of the Chinese medicine garden burnet in preparing antifungal medicine synergist |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104857116B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105030958A (en) * | 2015-08-27 | 2015-11-11 | 赵文华 | Pharmaceutical composition and application thereof |
CN106511420A (en) * | 2016-10-24 | 2017-03-22 | 中国人民解放军第二军医大学 | Novel purpose of cynanchi root as antifungal drug |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1051506A (en) * | 1990-10-08 | 1991-05-22 | 刘墨森 | Preparation method of novel sanguisorba officinalis preparation |
CN101167855A (en) * | 2007-11-01 | 2008-04-30 | 郑瑞 | Medicine for treating tinea pedis and tinea manuum |
-
2014
- 2014-02-21 CN CN201410060182.1A patent/CN104857116B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1051506A (en) * | 1990-10-08 | 1991-05-22 | 刘墨森 | Preparation method of novel sanguisorba officinalis preparation |
CN101167855A (en) * | 2007-11-01 | 2008-04-30 | 郑瑞 | Medicine for treating tinea pedis and tinea manuum |
Non-Patent Citations (1)
Title |
---|
金美花: "地榆药理作用与临床应用", 《现代医药卫生》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105030958A (en) * | 2015-08-27 | 2015-11-11 | 赵文华 | Pharmaceutical composition and application thereof |
CN106511420A (en) * | 2016-10-24 | 2017-03-22 | 中国人民解放军第二军医大学 | Novel purpose of cynanchi root as antifungal drug |
CN106511420B (en) * | 2016-10-24 | 2020-02-07 | 中国人民解放军第二军医大学 | New use of radix Cynanchi Atrati as antifungal agent |
Also Published As
Publication number | Publication date |
---|---|
CN104857116B (en) | 2018-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sharma et al. | Antifungal activity of Solanum melongena L, Lawsonia inermis L. and Justicia gendarussa B. against Dermatophytes | |
CN102973608A (en) | Application of effective part of cockroach extract in preparing drug for inhibiting fungus growth | |
CN110025717A (en) | Timosaponin digests conversion product and inhibits the application in skin superficial fungi drug in preparation | |
CN104857116B (en) | Application of the Chinese medicine garden burnet in preparing antifungal medicine synergist | |
Bokaeian et al. | Effects of garlic extract treatment in normal and streptozotocin diabetic rats infected with Candida albicans | |
CN1762967B (en) | Enoxolone derivative, preparation method and uses | |
Hassan | Study the effect of Quercus infectoria galls extracts on growth of Candida albicans and Candida glabrata in vitro which isolated from vaginal swabs | |
CN106177187B (en) | Tea polyphenol tea polysaccharide composition with synergistic, detoxifying and anti-cancer effects | |
CN108619367A (en) | A kind of Chinese medicine composition is preparing the application in preventing the drug of Acute cardiotoxicity caused by adriamycin | |
Wuthi-udomlert et al. | In vitro effectiveness of Acacia concinna extract against dermatomycotic pathogens | |
CN105031553B (en) | Medicinal composition for treating canine dermatophytosis, preparation method and application thereof | |
Sileshi et al. | Antibacterial and antifungal activities of extracts of some medicinal plants of Ethiopia | |
CN110755456A (en) | Antifungal medicine composition consisting of American cockroach extract and antifungal medicine | |
CN106511420B (en) | New use of radix Cynanchi Atrati as antifungal agent | |
CN111514203A (en) | Application of garden burnet charcoal in preventing and treating tinea corporis, tinea cruris, tinea manus and tinea pedis | |
CN102526117A (en) | Purpose of nutgall used for preparing antifungal medicine and antifungal medicine synergistic agent | |
CN103638055B (en) | Polyhachis vicina Roger extract and and antifungal pharmaceutical purposes thereof | |
CN102293972A (en) | Extract for adjusting female vaginal microecology | |
CN106913602A (en) | A kind of Ainaxiang gynecological lotion and its preparation method and application | |
CN104083360B (en) | A kind of Chinese medicine composition for the preparation of anti-aspergillosis medicine | |
CN108079026A (en) | A kind of application of phellinus linteus extract in antibacterials are prepared | |
CN113082150B (en) | Application of effective parts of deer medicine in the preparation of antifungal drugs and their synergists | |
CN115919919B (en) | Composition for inhibiting dermatophytes and application thereof | |
CN109700858A (en) | Rhizoma Polygoni suffulti is preparing the application in antifungal drug and its synergist | |
CN102872059B (en) | Application of Gypensapogenin B to preparing drugs for resisting human funguses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Cao Yongbing Inventor after: Ye Zhaojiao Inventor after: Jiang Yuanying Inventor after: Liu Mouzhi Inventor after: Yan Lan Inventor after: Li Hongjiao Inventor after: Wang Yan Inventor after: Cao Yingying Inventor after: Wang Ruilian Inventor before: Cao Yongbing Inventor before: Ye Zhaojiao Inventor before: Jiang Yuanying Inventor before: Liu Mouzhi Inventor before: Yan Lan Inventor before: Li Hongjiao Inventor before: Wang Yan Inventor before: Cao Yingying Inventor before: Wang Ruilian |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181102 |